Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
Farmers Insurance
McKesson
AstraZeneca
Harvard Business School

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 5,384,246

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,384,246
Title: Determination of ions in fluids by a process involving displacement of indicator ions
Abstract:A process and a reagent for the determination of ions in fluids, wherein the influence of these ions on the activity of an enzyme is measured. The ions for example are sodium, potassium, calcium, magnesium, manganese, lithium, lead, zinc, copper, iron or other heavy metals or non-metallic ions comprising chloride, bicarbonate, protons, ammonium and substances that give rise to ammonium. The enzymes which are used may be a transferase, a hydrolase, an oxidoreductase or a lyase. An essential feature is a method to exclude interferences by ions by masking the interfering ions with a binding agent.
Inventor(s): Berry; Michael N. (Eden Hills, AU), Town; Michael-Harold (Oberhausen, DE), Kresse; Georg-Burkhard (Penzberg, DE), Herrmann; Uwe (Bernried, DE)
Assignee: Boehringer Mannheim GmbH (Mannheim, DE) The Flinders University of South Australia (South Australia, AU)
Application Number:07/907,732
Patent Claims:see list of patent claims

Details for Patent 5,384,246

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Boehringer Mannheim GmbH (Mannheim, DE) The Flinders University of South Australia (South Australia, AU) 2012-01-24 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Chinese Patent Office
Healthtrust
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.